⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LEXX News
Lexaria Bioscience Corp. Common Stock
Lexaria Bioscience Corp. Provides Strategic Update
accessnewswire.com
LEXX
LEXXW
Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
accessnewswire.com
LEXX
LEXXW
Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain
accessnewswire.com
LEXX
LEXXW